Clinical significance of quantitative categorization of HER2 fluorescent in situ hybridization results in invasive breast cancer patients treated with HER2-targeted agents

MLA

Mohamed, Alhamar, et al. “Clinical Significance of Quantitative Categorization of HER2 Fluorescent in Situ Hybridization Results in Invasive Breast Cancer Patients Treated with HER2-Targeted Agents.” Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc, vol. 34, no. 4, May 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........664ca15bca35c149ebc0ff92fa666e4b&authtype=sso&custid=ns315887.

APA

Mohamed, A., Bassam, A., Harshita, M., Jessica, S., Haythem, A., Daniel, S., & Dhananjay A, C. (2020). Clinical significance of quantitative categorization of HER2 fluorescent in situ hybridization results in invasive breast cancer patients treated with HER2-targeted agents. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc, 34(4).

Chicago

Mohamed, Alhamar, Alkamachi Bassam, Mehrotra Harshita, Sanchez Jessica, Ali Haythem, Schultz Daniel, and Chitale Dhananjay A. 2020. “Clinical Significance of Quantitative Categorization of HER2 Fluorescent in Situ Hybridization Results in Invasive Breast Cancer Patients Treated with HER2-Targeted Agents.” Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc 34 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........664ca15bca35c149ebc0ff92fa666e4b&authtype=sso&custid=ns315887.